Newswise — December 27, 2021 – Certain factors reflecting lower socioeconomic status (SES) are linked to increased risks of cleft lip and/or cleft palate, reports a study in the January issue of Plastic and Reconstructive Surgery®, the official medical journal of the American Society of Plastic Surgeons (ASPS).
Different socioeconomic indicators are associated with different types of orofacial clefts – cleft lip with/without cleft palate (CLP) versus cleft palate only (CPO), according to the new research by Jordan W. Swanson, MD, MSc, Giap H. Vu, MD, and colleagues at the Children's Hospital of Philadelphia. "Previous research shows that children born into families with fewer resources often have delayed care and poorer outcomes from treatment," explains Dr. Swanson. "Here we looked at whether factors of poverty are associated with risk of having a cleft lip or palate in the first place."
Plastic and reconstructive surgeons are key members of the team of specialists providing care for children with cleft lip and cleft palate – one of the most common congenital anomalies.
Differing effects of SES on 'environmentally versus genetically determined' clefts
Dr. Swanson, Dr. Vu, and colleagues analyzed data from a US nationwide birth database, including approximately 6.25 million births in 2016 and 2017. Of these, 2,984 births (0.05 percent) were affected by CLP and 1,180 by CPO (0.02 percent).
The study examined a number of proxies for SES, including mother's level of education, use of the federal WIC program (Special Supplemental Nutrition Program for Women, Infants, and Children), and insurance status (Medicaid versus private insurance). These potential socioeconomic risk factors for CLP or CPO were analyzed with adjustment for other variables, including demographic factors, prenatal care, maternal health, and infant characteristics.
Some of the socioeconomic indicators were significantly associated with the risk of cleft lip/cleft palate. Maternal education was a protective factor, with a 27 percent lower risk of CLP for infants born to mothers who had a college degree or higher. In contrast, receiving WIC assistance was associated with a 25 percent increase in the risk of CPO. In adjusted analyses, Medicaid coverage was unrelated to the risk of CLP or CPO.
"Notably, early prenatal care was protective against the development of CLP," the researchers write. Delayed prenatal care was a risk factor for CLP: risk was increased by 14 percent for women who started prenatal care in the second trimester of pregnancy and 23 percent in the third trimester, compared to women who started prenatal care in the first trimester. In contrast, the timing of prenatal care was unrelated to the risk of CPO.
The study confirmed some previously known risk factors for orofacial clefts. Male sex, first-trimester smoking, and maternal gestational diabetes were all associated with an increased risk of CLP. Smoking and maternal infections before pregnancy were associated with an increased risk of CPO, while female sex was a protective factor against CPO.
As in previous studies, most risk factors for CPO did not overlap with those for CLP – supporting the theory that these two categories of clefts have different causative factors. Dr. Swanson, Dr. Vu, and colleagues write: "[T]he association between SES and orofacial clefts appears to differ by phenotype, with CLP being linked more strongly to environmentally-mediated ('nurture') factors, including socioeconomic factors, and CPO being more genetically-driven ('nature')."
The researchers speculate on some ways that socioeconomic factors might affect the risks of orofacial clefts. For example, mothers with higher education levels might be better informed about, and have better access to, prenatal care and adequate nutrition during pregnancy. The nutritional support provided to women enrolled in WIC might avoid the risk of "environmentally-determined" CLP, but not "genetically-determined" CPO.
Dr. Swanson, Dr. Vu, and colleagues hope their findings will help to clarify the previous mixed results on the relationship between SES and orofacial clefts. They call for further studies "to elucidate the mechanisms underlying the relationship between SES and risks of CLP and CPO in order to improve and implement public health policies aimed at reducing the burden of clefts and its disproportionate impact on socioeconomically disadvantaged populations."
Dr. Vu adds: "Such understandings and partnerships among researchers, health professionals, policymakers, social agencies, and local communities will allow us, as a society, to inch towards greater health parity."
DOI: 10.1097/PRS.0000000000008636
###
Plastic and Reconstructive Surgery® is published in the Lippincott portfolio by Wolters Kluwer.
About Plastic and Reconstructive Surgery
For over 75 years, Plastic and Reconstructive Surgery® (http://www.prsjournal.com/) has been the one consistently excellent reference for every specialist who uses plastic surgery techniques or works in conjunction with a plastic surgeon. The official journal of the American Society of Plastic Surgeons, Plastic and Reconstructive Surgery® brings subscribers up-to-the-minute reports on the latest techniques and follow-up for all areas of plastic and reconstructive surgery, including breast reconstruction, experimental studies, maxillofacial reconstruction, hand and microsurgery, burn repair and cosmetic surgery, as well as news on medico-legal issues.
About ASPS
The American Society of Plastic Surgeons is the largest organization of board-certified plastic surgeons in the world. Representing more than 7,000 physician members, the society is recognized as a leading authority and information source on cosmetic and reconstructive plastic surgery. ASPS comprises more than 94 percent of all board-certified plastic surgeons in the United States. Founded in 1931, the society represents physicians certified by The American Board of Plastic Surgery or The Royal College of Physicians and Surgeons of Canada.
About Wolters Kluwer
Wolters Kluwer (WKL) is a global leader in professional information, software solutions, and services for the clinicians, nurses, accountants, lawyers, and tax, finance, audit, risk, compliance, and regulatory sectors. We help our customers make critical decisions every day by providing expert solutions that combine deep domain knowledge with advanced technology and services.
Wolters Kluwer reported 2020 annual revenues of €4.6 billion. The group serves customers in over 180 countries, maintains operations in over 40 countries, and employs approximately 19,200 people worldwide. The company is headquartered in Alphen aan den Rijn, the Netherlands.
Wolters Kluwer provides trusted clinical technology and evidence-based solutions that engage clinicians, patients, researchers and students in effective decision-making and outcomes across healthcare. We support clinical effectiveness, learning and research, clinical surveillance and compliance, as well as data solutions. For more information about our solutions, visit https://www.wolterskluwer.com/en/health and follow us on LinkedIn and Twitter @WKHealth.
For more information, visit www.wolterskluwer.com, follow us on Twitter, Facebook, LinkedIn, and YouTube.